Literature DB >> 22350466

Accelerated recovery from nephrotic syndrome with acute renal failure by double filtration plasmapheresis in a patient with lupus podocytopathy.

Yoshitaka Iwazu1, Tetsu Akimoto, Sayoko Izawa, Makoto Inoue, Shigeaki Muto, Yasuhiro Ando, Kana Iwazu, Noriyoshi Fukushima, Wako Yumura, Eiji Kusano.   

Abstract

We describe a case of an adult female who presented with nephrotic syndrome. She was diagnosed with systemic lupus erythematosus with serum antinuclear antibodies, leucopenia with lymphopenia, butterfly erythema, and nephrotic syndrome. Renal biopsy revealed normal glomeruli with diffuse effacement of the foot processes, consistent with lupus podocytopathy. Although human albumin replacement was performed initially, acute renal failure developed rapidly. Therefore, she was treated with double filtration plasmapheresis (DFPP) in addition to oral steroid. After steroid therapy combined with DFPP, the renal function and proteinuria improved rapidly. Although the impact of DFPP on the treatment of lupus nephritis remains to be delineated, our observations suggest that DFPP in lupus podocytopathy played a pivotal role in facilitating the early recovery from renal injuries. Because of the rapid improvement of renal function without any change in body weight by DFPP, acute renal failure in the setting of lupus podocytopathy might contribute to an alternative pathophysiological factor for the diminished glomerular filtration rate, similar to that observed in the setting of idiopathic minimal change glomerulopathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350466     DOI: 10.1007/s10157-012-0606-6

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  26 in total

1.  Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a C1q column: a pilot study.

Authors:  B Pfueller; K Wolbart; A Bruns; G R Burmester; F Hiepe
Journal:  Arthritis Rheum       Date:  2001-08

2.  Lupus podocytopathy.

Authors:  Philip Shea-Simonds; Tom D Cairns; Candice Roufosse; Terry Cook; Tim J Vyse
Journal:  Rheumatology (Oxford)       Date:  2009-08-27       Impact factor: 7.580

3.  Recovery of both acute massive pulmonary hemorrhage and acute renal failure in a systemic lupus erythematosus patient with lupus anticoagulant by the combined therapy of plasmapheresis plus cyclophosphamide.

Authors:  D F Huang; S T Tsai; S R Wang
Journal:  Transfus Sci       Date:  1994-09

4.  Blood levels of endothelin-1 and thrombomodulin in patients with disseminated intravascular coagulation and sepsis.

Authors:  S Endo; K Inada; H Nakae; T Takakuwa; T Kasai; Y Yamada; T Suzuki; S Taniguchi; M Yoshida
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1995-11

5.  Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus.

Authors:  N Braun; C Erley; R Klein; I Kötter; J Saal; T Risler
Journal:  Nephrol Dial Transplant       Date:  2000-09       Impact factor: 5.992

6.  Comparative effects of plasmapheresis and intravenous cyclophosphamide on urinary podocyte excretion in patients with proliferative Lupus nephritis.

Authors:  T Nakamura; C Ushiyama; M Hara; S Osada; K Ugai; N Shimada; K Hayashi; I Ebihara; H Koide
Journal:  Clin Nephrol       Date:  2002-02       Impact factor: 0.975

7.  Minimal change disease with acute renal failure: a case against the nephrosarca hypothesis.

Authors:  Mary Ann Cameron; Usha Peri; Thomas E Rogers; Orson W Moe
Journal:  Nephrol Dial Transplant       Date:  2004-10       Impact factor: 5.992

Review 8.  LDL-apheresis and immunoadsorption: novel methods in the treatment of renal diseases refractory to conventional therapy.

Authors:  Władysław Sułowicz; Tomasz Stompór
Journal:  Nephrol Dial Transplant       Date:  2003-07       Impact factor: 5.992

9.  Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.

Authors:  Maria Giovanna Danieli; Carla Palmieri; Aldo Salvi; Maria Cristina Refe; Anna Stella Strusi; Giovanni Danieli
Journal:  J Clin Apher       Date:  2002       Impact factor: 2.821

10.  Glomerular podocytopathy in patients with systemic lupus erythematosus.

Authors:  Steven W Kraft; Melvin M Schwartz; Stephen M Korbet; Edmund J Lewis
Journal:  J Am Soc Nephrol       Date:  2004-11-17       Impact factor: 10.121

View more
  2 in total

1.  Labile Heme Aggravates Renal Inflammation and Complement Activation After Ischemia Reperfusion Injury.

Authors:  Li Wang; Vijith Vijayan; Mi-Sun Jang; Anja Thorenz; Robert Greite; Song Rong; Rongjun Chen; Nelli Shushakova; Igor Tudorache; Katja Derlin; Pooja Pradhan; Kukuh Madyaningrana; Nodir Madrahimov; Jan Hinrich Bräsen; Ralf Lichtinghagen; Cees van Kooten; Markus Huber-Lang; Hermann Haller; Stephan Immenschuh; Faikah Gueler
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

2.  Lupus podocytopathy superimposed on diabetic glomerulosclerosis: A case report.

Authors:  Lin Liu; Brian Murray; John E Tomaszewski
Journal:  Medicine (Baltimore)       Date:  2021-09-17       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.